top of page
Browse by category
Search


ESG represents a safe, minimally invasive and versatile intervention for obesity
A qualitative narrative review by researchers at St George’s University, St George’s, Grenada, has reported that endoscopic sleeve gastroplasty (ESG) represents a safe, minimally invasive and versatile intervention for obesity, occupying a unique position between conservative medical therapy and surgical bariatric procedures. According to the researchers, their review highlights ESG’s ability to produce meaningful weight loss and metabolic improvements while minimising proced


Boston Scientific introduces Endura Weight Loss Solutions
Boston Scientific has introduced its Endura Weight Loss Solutions representing a range of weight loss procedures, including endoscopic...


NICE draft guidance approves of ESG as an option to treat obesity
The UK’s National Institute for Health and Care Excellence (NICE) has issued draft guidance stating that endoscopic sleeve gastroplasty...


Apollo’s ESG and REVISE Systems approved by FDA
Apollo Endosurgery has been granted marketing authorisation for its ESG, ESG Sx, REVISE and REVISE Sx through the FDA’s De Novo...
Browse by tag






bottom of page
